Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics

ARWR POWR Grades

• Growth is the dimension where ARWR ranks best; there it ranks ahead of 80.52% of US stocks.
• ARWR's strongest trending metric is Growth; it's been moving up over the last 47 weeks.
• ARWR's current lowest rank is in the Momentum metric (where it is better than 7.03% of US stocks).

ARWR Stock Summary

• Of note is the ratio of Arrowhead Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 11.6% of US stocks have a lower such ratio.
• With a price/sales ratio of 62.38, Arrowhead Pharmaceuticals Inc has a higher such ratio than 95.75% of stocks in our set.
• Over the past twelve months, ARWR has reported earnings growth of 290.23%, putting it ahead of 91.83% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to Arrowhead Pharmaceuticals Inc, a group of peers worth examining would be ALLO, ARVN, FATE, IMTX, and CUE.
• ARWR's SEC filings can be seen here. And to visit Arrowhead Pharmaceuticals Inc's official web site, go to arrowheadpharma.com.

ARWR Valuation Summary

• ARWR's price/earnings ratio is -55.6; this is 252.33% lower than that of the median Healthcare stock.
• ARWR's price/sales ratio has moved NA NA over the prior 209 months.
• Over the past 209 months, ARWR's EV/EBIT ratio has gone NA NA.

Below are key valuation metrics over time for ARWR.

ARWR Growth Metrics

• Its 5 year cash and equivalents growth rate is now at 216.02%.
• Its 5 year net income to common stockholders growth rate is now at 110.37%.
• The 4 year price growth rate now stands at 514.16%.

ARWR's revenue has moved up $107,255,855 over the prior 70 months.

The table below shows ARWR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	107.6379	184.491	-125.9067
2021-03-31	89.12263	180.6738	-109.5939
2020-12-31	79.84049	-110.7831	-102.6115
2020-09-30	87.99207	-95.39157	-84.55323
2020-06-30	123.652	-70.73164	-24.41561
2020-03-31	138.9728	-26.77773	9.531315

ARWR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ARWR has a Quality Grade of C, ranking ahead of 55.58% of graded US stocks.
• ARWR's asset turnover comes in at 0.171 -- ranking 212th of 677 Pharmaceutical Products stocks.
• CRBP, ASRT, and VBIV are the stocks whose asset turnover ratios are most correlated with ARWR.

The table below shows ARWR's key quality metrics over time.